Science & Technology
Enzyme-based Nerve-agent Attenuation (ATHENA)
Department of Defense — Office for Chemical and Biological Defense
Opportunity #: W911NF-25-P-A012
Award Ceiling
$210K
Award Floor
$210K
Close Date
Feb 17, 2026
Total Funding
$210K
Expected Awards
1
Posted Date
Jul 25, 2025
Cost Sharing Required
No
Grants.gov ID
sbir-W911NF-25-P-A012
Description
SBIR Phase Phase I award: "Enzyme-based Nerve-agent Attenuation (ATHENA)" awarded to NOU SYSTEMS INC in HUNTSVILLE, Alabama. Funded by Department of Defense (Office for Chemical and Biological Defense). Award amount: $209,542.11. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.